Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals

Okonofua, Eni C., Simpson, Kit N., Jesri, Ammar, Rehman, Shakaib U., Durkalski, Valerie L., Egan, Brent M.·2006·Hypertension

Cited by (527)

Items 101–200 of 527

  1. Measure Accurately, Act Rapidly, and Partner With Patients ( MAP ) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results
    Robert B Hanlin, Irfan M. Asif, Gregory Dean Wozniak, Susan E. Sutherland, Bijal Shah, Jianing Yang, Robert A. Davis, Sean T. Bryan, Michael Rakotz, Brent M. Egan · 2018 · Journal of Clinical Hypertension
  2. Review of Long-Term Blood Pressure Control After Intracerebral Hemorrhage: Challenges and Opportunities
    Michael T. Mullen, Craig S. Anderson · 2022 · Stroke
  3. Combination therapy for the management of hypertension: A review of the evidence
    Nitesh A. Sood, Kurt M. Reinhart, William L. Baker · 2010 · American Journal of Health-System Pharmacy
  4. Hypertension Control at Physicians' Offices in the United States
    Jing Fang, Michael H. Alderman, Nora L. Keenan, Carma Ayala, Janet B. Croft · 2008 · American Journal of Hypertension
  5. Comparison of Information Content of Structured and Narrative Text Data Sources on the Example of Medication Intensification
    Alexander Turchin, Maria Shubina, Eugene M Breydo, M. L. Pendergrass, Jonathan S. Einbinder · 2009 · Journal of the American Medical Informatics Association
  6. Impact of Nonadherence to Antihypertensive Therapy
    Aram V. Chobanian · 2009 · Circulation
  7. Home blood pressure data visualization for the management of hypertension: designing for patient and physician information needs
    Richelle J. Koopman, Shannon M. Canfield, Jeffery L. Belden, Pete Wegier, Victoria A. Shaffer, K. D. Valentine, Akshay Jain, Linsey M. Barker Steege, Sonal J. Patil, Mihail Popescu et al. · 2020 · BMC Medical Informatics and Decision Making
  8. Therapeutic Inertia in the Outpatient Management of Dyslipidemia in Patients With Ischemic Heart Disease. The Inertia Study
    Pablo Lázaro, Nekane Murga, Dolores L. Aguilar, Miguel Ángel Hernández-Presa · 2010 · Revista Española de Cardiología (English Edition)
  9. Understanding Racial Disparities in Treatment Intensification for Hypertension Management
    Meredith G. Manze, Adam J. Rose, Michelle B. Orner, Dan R. Berlowitz, Nancy R. Kressin · 2010 · Journal of General Internal Medicine
  10. [Cardiovascular risk factors in an urban Colombia population].
    Fredy Alonso Patiño Villada, Elkin Fernando Arango Vélez, Mario Andrés Quintero Velásquez, Mónica M. Arenas-Sosa · 2011 · PubMed
  11. Hypertensive Crisis
    Deborah Taylor · 2015 · Critical Care Nursing Clinics of North America
  12. Self-Reported Influences of Hopelessness, Health Literacy, Lifestyle Action, and Patient Inertia on Blood Pressure Control in a Hypertensive Emergency Department Population
    JaNae Joyner, David L. Mount, Orita D. McCorkle, Debra R. Simmons, Carlos Maria Ferrario, David Martin Cline · 2009 · The American Journal of the Medical Sciences
  13. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study
    Henry A. Punzi, Joel M. Neutel, Dean J. Kereiakes, Ali Shojaee, William F. Waverczak, Robert Dubiel, Jen‐Fue Maa · 2010 · Therapeutic Advances in Cardiovascular Disease
  14. Practical solutions to the challenges of uncontrolled hypertension: a white paper
    Josep Redón, Hans Rudolf Brunner, Claudio Ferri, Karl F. Hilgers, R. E. Rahn Kolloch, Gert A. van Montfrans · 2008 · Journal of Hypertension
  15. Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Randomized Controlled Trial
    Amy G. Huebschmann, Trina Mizrahi, Alyssa Soenksen, Brenda L. Beaty, Thomas D. Denberg · 2012 · Journal of Clinical Hypertension
  16. Barriers to Blood Pressure Control: A STITCH Substudy
    Sigrid Nelson, George K. Dresser, Margaret K. Vandervoort, Cindy J. Wong, Brian G. Feagan, Jeffrey L. Mahon, Ross D. Feldman · 2010 · Journal of Clinical Hypertension
  17. Evaluation and management of the patient with difficult-to-control or resistant hypertension.
    Anthony J. Viera, Alan L. Hinderliter · 2009 · PubMed
  18. Community pharmacists, medication monitoring, and the routine nature of refills: A qualitative study
    Matthew J. Witry, William R. Doucette · 2014 · Journal of the American Pharmacists Association
  19. Therapeutic strategies to improve control of hypertension
    Pedro Armario, Bernard Waeber · 2013 · Journal of Hypertension
  20. Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension
    Nelson Wang, Abdul Salam, Ruth J Webster, Asita de Silva, Rama Krishna Guggilla, Sandrine Stepien, Jayanthi Mysore, Laurent Billot, Stephen Jan, Pallab Kumar Maulik et al. · 2020 · JAMA Cardiology
  21. A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension
    J. M. Neutel, Stanley S. Franklin, Pablo Lapuerta, Amitabha Bhaumik, Agata Ptaszynska · 2007 · Journal of Human Hypertension
  22. First Things First: Difficulty with Current Medications Is Associated With Patient Willingness to Add New Ones
    B. Zikmund-Fisher, T. Hofer, M. Klamerus, E. Kerr · 2009 · Patient
  23. Control of Medical Comorbidities in Individuals With HIV
    Anne Kress Monroe, Geetanjali Chander, Richard D. Moore · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  24. Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial
    Daniel Huber, Robin Henriksson, Stina Jakobsson, Thomas Mooe · 2017 · PLoS ONE
  25. Phone-based Intervention under Nurse Guidance after Stroke (PINGS): study protocol for a randomized controlled trial
    Sarfo, Fred Stephen, Treiber, Frank, Jenkins, Carolyn, Patel, Sachin, Gebregziabher, Mulugeta, Singh, Arti, Sarfo-Kantanka, Osei, Saulson, Raelle, Appiah, Lambert, Oparebea, Eunice et al. · 2016 · Trials
  26. Mixed methods feasibility study for a trial of blood pressure telemonitoring for people who have had stroke/transient ischaemic attack (TIA)
    J. Hanley, P. Fairbrother, A. Krishan, L. McCloughan, P. Padfield, M. Paterson, H. Pinnock, A. Sheikh, C. Sudlow, A. Todd et al. · 2015 · Trials
  27. Biases and imperatives in handling medical technology
    Bjørn Hofmann · 2019 · Health Policy and Technology
  28. Hospitalization for Uncomplicated Hypertension: An Ambulatory Care Sensitive Condition
    Robin L. Walker, Guanmin Chen, Finlay Aleck McAlister, Norm R.C. Campbell, Brenda R. Hemmelgarn, Elijah Dixon, William Amin Ghali, Doreen M. Rabi, Karen Tu, Nathalie Jetté et al. · 2013 · Canadian Journal of Cardiology
  29. Simplistic and complex thought in medicine: the rationale for a person-centered care model as a medical revolution
    Gérard Reach · 2016 · Patient Preference and Adherence
  30. Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?
    Samar A. Nasser, Zongshan Lai, Shannon O’Connor, Xuefeng Liu, John M. Flack · 2008 · Current Hypertension Reports
  31. Novel Use of Kaplan–Meier Methods to Explain Age and Gender Differences in Hypertension Control Rates
    Kent R. Bailey, Brandon R. Grossardt, John W. Graves · 2008 · Hypertension
  32. Pharmacist‐physician collaborative care model and time to goal blood pressure in the uninsured population
    Dave L. Dixon, Evan M. Sisson, Eric D. Parod, Benjamin W. Van Tassell, Pramit Amrutlal Nadpara, Daniel E. Carl, Alan W. Dow · 2017 · Journal of Clinical Hypertension
  33. Home and Online Management and Evaluation of Blood Pressure (HOME BP) digital intervention for self-management of uncontrolled, essential hypertension: a protocol for the randomised controlled HOME BP trial
    R. Band, K. Morton, B. Stuart, J. Raftery, K. Bradbury, G. Yao, Shi-Hua Zhu, P. Little, L. Yardley, R. McManus · 2016 · BMJ Open
  34. The Accuracy of Clinician Perceptions of “Usual” Blood Pressure Control
    Adam J. Rose, Stephanie L. Shimada, James A. Rothendler, Joel I. Reisman, Peter A. Glassman, Dan R. Berlowitz, Nancy R. Kressin · 2007 · Journal of General Internal Medicine
  35. Total Cardiovascular Risk Management
    Eberhard Ritz · 2007 · The American Journal of Cardiology
  36. The Effects of an Olmesartan Medoxomil–Based Treatment Algorithm on 24‐Hour Blood Pressure Levels in Elderly Patients Aged 65 and Older
    Dean J. Kereiakes, Joel Neutel, Kathy A. Stoakes, William F. Waverczak, Jianbo Xu, Ali Shojaee, Robert Dubiel · 2009 · Journal of Clinical Hypertension
  37. Evolution of therapy inertia in primary care setting in Spain during 2002–2010
    Carlos Escobar, Vivencio Barrios, F. Javier Alonso-Moreno, Miguel Ángel Prieto-Díaz, Francisco Valls, Alberto Calderón, Jose Luis Llisterri · 2014 · Journal of Hypertension
  38. Measure accurately, Act rapidly, and Partner with patients: An intuitive and practical three‐part framework to guide efforts to improve hypertension control
    Romsai Tony Boonyasai, Michael Rakotz, Lisa H. Lubomski, Donna M. Daniel, Jill A. Marsteller, Kathryn Taylor, Lisa A. Cooper, Omar Hasan, Matthew K. Wynia · 2017 · Journal of Clinical Hypertension
  39. Guidance for the Interpretation of Continual Cuffless Blood Pressure Data for the Diagnosis and Management of Hypertension
    Josep Solà, Meritxell Cortés, David Perruchoud, Bastien De Marco, Melvin David Lobo, Cyril Pellaton, Grégoire Wuerzner, Naomi D.L. Fisher, Jay Shah · 2022 · Frontiers in Medical Technology
  40. Risk factors associated with uncontrolled hypertension: findings from the baseline CARMEN survey in Cienfuegos, Cuba
    Pedro Ordúñez, Alberto Barceló, José Luis Bernal Sobrino, Alfredo Espinosa, Luis C Silva, Richard Cooper · 2008 · Journal of Hypertension
  41. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy
    Jan Basile, Joel Neutel · 2009 · Therapeutic Advances in Cardiovascular Disease
  42. Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice
    Denis Pouchain, Michel M Lièvre, D. Huas, Jean‐Pierre Lebeau, Vincent Renard, Éric Bruckert, Xavier J. Girerd, Florent Boutitie · 2013 · Trials
  43. Comparing Methods of Measuring Treatment Intensification in Hypertension Care
    Adam J. Rose, Dan R. Berlowitz, Meredith G. Manze, Michelle B. Orner, Nancy R. Kressin · 2009 · Circulation Cardiovascular Quality and Outcomes
  44. Adherence to Antihypertensive Medications: Current Status and Future Directions
    Joshua A. Rash, Kim Lavoie, Ross D. Feldman, Tavis S. Campbell · 2014 · Current Cardiovascular Risk Reports
  45. Research strategies in treatment of hypertension: value of retrospective real-life data
    Giovanni Corrao, Giuseppe Mancia · 2021 · European Heart Journal
  46. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial
    A. Zheutlin, F. Mondesir, C. Derington, J. King, Chong Zhang, J. Cohen, D. Berlowitz, D. E. Anstey, W. Cushman, Tom H. Greene et al. · 2022 · JAMA Network Open
  47. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial
    Suzanne Oparil, Steven G. Chrysant, Michael R. Melino, J Lee, S Karki, Reinilde Heyrman · 2010 · Journal of Human Hypertension
  48. Phone-Based Intervention under Nurse Guidance after Stroke (PINGS II) Study: Protocol for a Phase III Randomized Clinical Trial
    Fred Stephen Sarfo, Albert Kwaku Akpalu, Ansumana Sandy Bockarie, Lambert Tetteh Appiah, Samuel Blay Nguah, Nana Kwame Ayisi‐Boateng, Sheila Adamu, Christiana Neizer, Agnes Arthur, Richard King Nyamekye et al. · 2021 · Journal of Stroke and Cerebrovascular Diseases
  49. Adherence to Guideline-Directed Medical Treatments in Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy
    Gianluigi Savarese, Felix Lindberg, Antonio Nicola Cannata, Marianna Adamo, Giuseppe Ambrosio, Pietro Ameri, Markus S. Anker, Magnus Bäck, Antoni Bayés‐Genís, Tuvia Ben Gal et al. · 2025 · European Journal of Heart Failure
  50. Effectiveness of a multidisciplinary intervention to improve hypertension control in an urban underserved practice
    Robert J. Fortuna, Angela K. Nagel, Emily Rose, Robert M. McCann, John C. Teeters, Denise D. Quigley, John D. Bisognano, Sharon Legette-Sobers, Chang Liu, Thomas A. Rocco · 2015 · Journal of the American Society of Hypertension
  51. Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education
    Gustavo Saposnik, Jorge Mauriño, Ángel Pérez Sempere, María Terzaghi, Christian Carl Ruff, Muhammad Mamdani, Philippe N. Tobler, Xavier Montalbán · 2017 · Frontiers in Neurology
  52. Clinical inertia in hypertension: a new holistic and practical concept within the cardiovascular continuum and clinical care process
    Vicente Pallarés‐Carratalá, Irene Bonig-Trigueros, Antonio Palazón‐Bru, María José Esteban-Giner, Vicente Francisco Gil-Guillén, Vicente Giner Galvañ · 2019 · Blood Pressure
  53. The Cardiovascular Risk Factor, Left Ventricular Hypertrophy, Is Highly Prevalent in Stable, Treated Angina Pectoris
    D. S. C. Ang, Stuart D. Pringle, Allan D. Struthers · 2007 · American Journal of Hypertension
  54. Controlling hypertension from a public health perspective
    Jun R. Chiong · 2008 · International Journal of Cardiology
  55. Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model
    Valy Fontil, Kirsten B. Bibbins-Domingo, Dhruv S. Kazi, Stephen Sidney, Pamela G. Coxson, Raman Ravi Khanna, Ronald G. Victor, Mark J. Pletcher · 2015 · Journal of General Internal Medicine
  56. Simplified therapeutic intervention to control hypertension and hypercholesterolemia
    George K. Dresser, Sigrid Nelson, Jeffrey L. Mahon, Guangyong Zou, Margaret K. Vandervoort, Cindy J. Wong, Brian G. Feagan, Ross D. Feldman · 2013 · Journal of Hypertension
  57. Assessing Mobile Health Capacity and Task Shifting Strategies to Improve Hypertension Among Ghanaian Stroke Survivors
    Michelle G. Nichols, Fred Stephen Sarfo, Arti Singh, Suparna Qanungo, Frank Anton Treiber, Bruce I Ovbiagele, Raelle Saulson, Sachin K. Patel, Carolyn M. Jenkins · 2017 · The American Journal of the Medical Sciences
  58. Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain
    Noora Almusalam, Jiwon Oh, María Terzaghi, Jorge Mauriño, Fabien Bakdache, Alonso G. Montoya, Fernando Cáceres, Gustavo Saposnik · 2019 · JAMA Network Open
  59. Biases distorting priority setting
    Bjørn Hofmann · 2019 · Health Policy
  60. Optimizing Hypertension Management in Underserved Rural Populations
    Bradley Field Bale · 2010 · Journal of the National Medical Association
  61. Relationship between health‐related quality of life and blood pressure control in patients with uncontrolled hypertension
    Chan Joo Lee, Woo Jung Park, Jung‐Won Suh, Eue‐Keun Choi, Dong Woon Jeon, Sang‐Wook Lim, Daehyeok Kim, Kwang Soo Cha, Bong-Ryeol Lee, Nam‐Ho Kim et al. · 2020 · Journal of Clinical Hypertension
  62. Impact of Therapeutic Inertia on Long-Term Blood Pressure Control
    Alexandry Augustin, Louise V. Coutts, Lorenzo Zanisi, Anthony S. Wierzbicki, Francesco Shankar, Phil Chowienczyk, Christopher Nicholas Floyd · 2021 · Hypertension
  63. Compliance with treatment of patients with hypertension in Almadinah Almunawwarah: A community-based study
    Manal Ibrahim Hanafi Mahmoud · 2012 · Journal of Taibah University Medical Sciences
  64. mHealth medication and blood pressure self-management program in Hispanic hypertensives: a proof of concept trial
    John C. Sieverdes, Gregoski, Sachin K. Patel, Williamson, Brunner-Jackson, Rundbaken, Treiber, Lydia K. Davidson, Frank Anton Treiber · 2013 · Smart Homecare Technology and TeleHealth
  65. Results of an Olmesartan Medoxomil–Based Treatment Regimen in Hypertensive Patients
    Suzanne Oparil, Steven G. Chrysant, Dean J. Kereiakes, Jianbo Xu, Kathleen J. Chavanu, William F. Waverczak, Robert Dubiel · 2008 · Journal of Clinical Hypertension
  66. Clinical Inertia in Poorly Controlled Elderly Hypertensive Patients: A Cross-Sectional Study in Spanish Physicians to Ascertain Reasons for Not Intensifying Treatment
    Vicente Francisco Gil-Guillén, Domingo Orozco‐Beltrán, Concepción Carratalá‐Munuera, Emilio Márquez Contreras, Ramón Durazo-Arvizú, Richard Cooper, Salvador Pertusa Martínez, Salvador Pita‐Fernández, Diego González-Segura Alsina, José Luis Martin-de-Pablo et al. · 2013 · American Journal of Cardiovascular Drugs
  67. El control de la inercia terapéutica en el tratamiento de la hipertensión arterial mediante diferentes estrategias
    Emilio Márquez Contreras, Nieves Martel Claros, Vicente Francisco Gil-Guillén, J.L. Martín de Pablos, Mariano De La Figuera Von Wichman, J.J. Casado Martínez, Jacinto Espinosa García · 2009 · Atención Primaria
  68. Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists
    Gustavo Saposnik, Xavier Montalbán, Daniel H. Selchen, María Terzaghi, Fabien Bakdache, Alonso G. Montoya, Manuel Fruns Q., Fernando Cáceres, Jiwon Oh · 2018 · Frontiers in Neurology
  69. Improving Hypertension Control Rates: Technology, People, or Systems?
    Daniel W. Jones · 2008 · JAMA
  70. Novel pharmacological approaches to lowering blood pressure and managing hypertension
    Matthew Sayer, David John Webb, Neeraj Dhaun · 2025 · Nature Reviews Cardiology
  71. Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals
    W.J. Elliott · 2007 · Yearbook of Cardiology
  72. Personal Continuity of Care in a University-Based Primary Care Practice: Impact on Blood Pressure Control
    Nik Sherina Hanafi, Adina Binti Abdullah, Ping Yein Lee, Su May Liew, Yook Chin Chia, Ee Ming Khoo · 2015 · PLoS ONE
  73. Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study
    Simone Lorenzo Romano, Chiara Idolazzi, Cristiano Fava, Luigi Fondrieschi, Mario Celebrano, Pietro Delva, Lorella Branz, Angela Di Donato, Andrea Dalbeni, Pietro Minuz · 2018 · High Blood Pressure & Cardiovascular Prevention
  74. Highly Interactive Multi‐Session Programs Impact Physician Behavior on Hypertension Management: Outcomes of a New CME Model
    Carole Drexel, Kathy Merlo, JAN N. BASILE, Barry Watkins, Ben Whitfield, Jay M. Katz, Brad Pine, Tom Sullivan · 2010 · Journal of Clinical Hypertension
  75. Epidemiology and Unmet Needs in Hypertension
    John M. Flack · 2007 · Journal of Managed Care Pharmacy
  76. Real‐world impact of once‐weekly subcutaneous semaglutide after 2 years of follow‐up: Results from a nationwide observational study in people with type 2 diabetes
    Vilsbøll, Tina, Lindahl, Caroline Ø., Nielsen, Nick F., Tikkanen, Christian K. · 2023 · Diabetes, Obesity and Metabolism
  77. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke
    Michael Anthony Valentino, Jad Al Danaf, Andrew Panakos, Loheetha Ragupathi, Danielle Duffy, David J. Whellan · 2016 · American Heart Journal
  78. Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension
    Kostas Tsioufis, Στέλλα Δούμα, Manolis S. Kallistratos, Athanasios John Manolis · 2019 · Clinical Drug Investigation
  79. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension
    William B. White · 2008 · Blood Pressure Monitoring
  80. Management of hypertension with fixed-dose triple-combination treatments
    Benjamin J Epstein, Niren K Shah, Nancy Borja‐Hart · 2013 · Therapeutic Advances in Cardiovascular Disease
  81. Effect of an intensive nurse-managed medical care programme on ambulatory blood pressure in hypertensive patients
    Kurt Ulm, Ulrich Huntgeburth, Hans Gnahn, Claus Briesenick, Klaus Pürner, Martin Middeke · 2010 · Archives of cardiovascular diseases
  82. Role of combination therapy in the treatment of hypertension: Focus on valsartan plus amlodipine
    Claudio Ferri, Giuseppe Croce, Giovambattista Desideri · 2008 · Advances in Therapy
  83. General practitioners’ justifications for therapeutic inertia in cardiovascular prevention: an empirically grounded typology
    Jean‐Pierre Lebeau, Jean‐Sébastien Cadwallader, Hélène Vaillant-Roussel, Denis Pouchain, Virginie Yaouanc, Isabelle Aubin-Auger, Alain Mercier, Emmanuel Rüsch, Roy Remmen, Etienne Vermeire et al. · 2016 · BMJ Open
  84. Blood Pressure Control in Italian Essential Hypertensives Treated by General Practitioners
    Cristina Giannattasio, M. Cairó, Francesca Cesana, Marta Alloni, Paola Sormani, Giulia Colombo, G. Grassi, G. Mancia · 2012 · American Journal of Hypertension
  85. Epoetin Therapy and Hemoglobin Level Variability in Nondialysis Patients with Chronic Kidney Disease
    Roberto Minutolo, Paolo Chiodini, Bruno Cianciaruso, Andrea Pota, Vincenzo Bellizzi, Deborah Avino, Sara Mascia, Simona Laurino, Valerio Bertino, Giuseppe Conte et al. · 2009 · Clinical Journal of the American Society of Nephrology
  86. Is There a Predictive Profile for Clinical Inertia in Hypertensive Patients?
    Vicente Francisco Gil-Guillén, Domingo Orozco‐Beltrán, Emilio Márquez Contreras, Ramón Durazo-Arvizú, Richard Cooper, Salvador Pita‐Fernández, Diego González-Segura Alsina, Concepción Carratalá‐Munuera, José Luis Martín de Pablo, Vicente Pallarés‐Carratalá et al. · 2011 · Drugs & Aging
  87. Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets?
    Brent M. Egan, Marilyn A. Laken · 2011 · Current Opinion in Cardiology
  88. Implementation of home blood pressure monitoring among French GPs: A long and winding road
    Giselle Dugelay, Joëlle Kivits, Louise Desse, Jean‐Marc Boivin · 2019 · PLoS ONE
  89. Antihypertensive Medication Prescribing Patterns in a University Teaching Hospital
    Robert Neal Axon, Paul J. Nietert, Brent M. Egan · 2010 · Journal of Clinical Hypertension
  90. Are self-reported telemonitored blood pressure readings affected by end-digit preference: a prospective cohort study in Scotland
    R. Parker, M. Paterson, P. Padfield, H. Pinnock, J. Hanley, Vicky Hammersley, A. Steventon, B. McKinstry · 2018 · BMJ Open
  91. Phone-based Intervention under Nurse Guidance after Stroke: Concept for Lowering Blood Pressure after Stroke in Sub-Saharan Africa
    Bruce I Ovbiagele · 2014 · Journal of Stroke and Cerebrovascular Diseases
  92. Consensus study to define appropriate inaction and inappropriate inertia in the management of patients with hypertension in primary care
    Jean‐Pierre Lebeau, Julie Biogeau, Maxime Carré, Alain Mercier, Isabelle Aubin-Auger, Emmanuel Rüsch, Roy Remmen, Etienne Vermeire, Kristin Hendrickx · 2018 · BMJ Open
  93. Objective for 2015: 70% of treated and controlled hypertensive patients. Seven key points to reach this goal in practice. A joint call for action of the French League Against Hypertension and the French Society of Hypertension
    Jean‐Jacques Mourad, Xavier J. Girerd · 2012 · Journal des Maladies Vasculaires
  94. Impacting Population Cardiovascular Health Through a Community‐Based Practice Network: Update on an ASH‐Supported Collaborative
    Brent M. Egan, Marilyn A. Laken, C. Shaun Wagner, Sheryl S. Mack, Kim Seymour‐Edwards, John A. Dodson, Yumin Zhao, Daniel T. Lackland · 2011 · Journal of Clinical Hypertension
  95. New Concepts in Hypertension Management: A Population-Based Perspective
    Richard V. Milani, Carl J. Lavie, Jonathan K. Wilt, Robert Bober, Héctor O. Ventura · 2016 · Progress in Cardiovascular Diseases
  96. Therapeutic inertia and contributing factors among ambulatory patients with hypertension
    Yirga Legesse Niriayo, Solomon Girmay, Nigusse Tesfay, Kidu Gidey, Solomon Weldegebreal Asgedom · 2024 · BMC Cardiovascular Disorders
  97. Hypertension control in sub‐Saharan Africa: Clinical inertia is another elephant in the room
    Eva L. van der Linden, Charles O Agyemang, Bert‐Jan H. van den Born · 2020 · Journal of Clinical Hypertension
  98. Single-Pill Triple-Combination Therapy: An Alternative to Multiple-Drug Treatment of Hypertension
    Steven G. Chrysant · 2011 · Postgraduate Medicine
  99. Adequacy of blood pressure control and level of adherence with antihypertensive therapy
    Loice Achieng, MD Joshi, E. N. Ogola, E M Karari · 2010 · East African Medical Journal
  100. One-Year Rates and Determinants of Poststroke Systolic Blood Pressure Control among Ghanaians
    Fred Stephen Sarfo, Gloria Kyem, Bruce Ovbiagele, John Akassi, Osei Sarfo‐Kantanka, Martin Kofi Agyei, Elizabeth Badu, Nathaniel Adusei Mensah · 2016 · Journal of Stroke and Cerebrovascular Diseases